Status:

COMPLETED

ED90 of Norepinephrine and Phenylephrine Infusions in Preeclamptic Patients

Lead Sponsor:

General Hospital of Ningxia Medical University

Conditions:

Adverse Effect

Eligibility:

FEMALE

18-45 years

Phase:

NA

Brief Summary

The objective of this study is to investigate the ED90 of norepinephrine and phenylephrine infusions for preventing postspinal anesthesia hypotension under intensive treatment in preeclamptic patients...

Detailed Description

Post-spinal anesthesia hypotension is a frequent complication during spinal anesthesia for cesarean section. The incidence of post-spinal anesthesia hypotension is as high as 62.1-89.7% if prophylacti...

Eligibility Criteria

Inclusion

  • 18-45 years
  • Primipara or multipara
  • Singleton pregnancy ≥32 weeks
  • American Society of Anesthesiologists physical status classification II to III
  • Scheduled for cesarean section under spinal anesthesia

Exclusion

  • Baseline blood pressure ≥160 mmHg
  • Body height \< 150 cm
  • Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2
  • Eclampsia or chronic hypertension
  • Hemoglobin \< 7g/dl
  • Fetal distress, or known fetal developmental anomaly

Key Trial Info

Start Date :

October 3 2024

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 20 2025

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT06158022

Start Date

October 3 2024

End Date

May 20 2025

Last Update

October 6 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

General hospital of Ningxia University

Yinchuan, Ningxia, China, 750004